Evidence map›Paper›PMID 33434177›Full record

ArticleEndocrinology, diabetes & metabolism case reports2020

Pheochromocytoma crisis with cyclic fluctuation in blood pressure mimics acute coronary syndrome.

Mitsuhiro Kometani, Takashi Yoneda, Yuji Maeda, Masashi Oe, Yoshimichi Takeda, Takuya Higashitani, Daisuke Aono, Asuka Yoshino, Shigehiro Karashima, Yoshiyu Takeda

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. An atypical manifestation of pheochromocytoma crisis: Acute delirium.Journal of family medicine and primary care · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mitsuhiro KometaniDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Takashi YonedaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Yuji MaedaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Masashi OeDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Yoshimichi TakedaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Takuya HigashitaniDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.ORCID 0000-0002-5809-2003
Daisuke AonoDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Asuka YoshinoDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Shigehiro KarashimaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Yoshiyu TakedaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Kanazawa University · JPPublic Central Hospital of Matto Ishikawa · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summaryPheochromocytoma crisis results from the sudden release of large quantities of catecholamines and leads to progressive multiple organ dysfunction. Here we report a case of pheochromocytoma crisis with symptoms associated with acute coronary syndrome (ACS) and severe fluctuations in blood pressure (BP). A 43-year-old Japanese man with hypertension (240/120 mmHg) visited a general hospital for chest pain. Echocardiogram showed ST segment depression and blood test demonstrated elevated troponin T. However, emergent coronary angiography revealed normal findings. CT showed a large adrenal mass on the left side, which was suspected as the cause of chest pain and BP elevation. After the patient was transported to our hospital, his BP was found to oscillate between 70 and 240 mmHg, and level of consciousness was decreased. After hospitalization, he had a further decrease in consciousness, a rise in body temperature, and a gradual increase in the interval between the upper and lower systolic BP. His systolic BP varied between 30 mmHg and 300 mmHg at the intervals of 20-30 min. After a multimodality therapy, including α-blocker and high dose fluid replacement, the fluctuation in his BP was gradually decreased and got stabilized after approximately 24 h. Approximately 3 weeks later, he underwent left adrenalectomy. This case showed that pheochromocytoma with internal necrosis might be misdiagnosed as ACS. Furthermore, in cases with a large adrenal tumor and severe elevation or fluctuations of BP, pheochromocytoma should be suspected and treated with α-blockers and fluid replacements as soon as possible prior to surgery. LEARNING POINTS: High catecholamine levels due to pheochromocytoma crisis might cause symptoms associated with acute coronary syndrome. Adrenal tumor with internal necrosis and the elevation or fluctuations of blood pressure should be suspected to be pheochromocytoma. If pheochromocytoma crisis is suspected, the specialist, such as an endocrinologist or a urologist, should intervene, and an α-blocker treatment with adequate fluid replacement therapy should be initiated as soon as possible. Pheochromocytoma multisystem crisis (PMC) is a fatal condition characterized by multiple organ failure, severe blood pressure variability, high fever, and encephalopathy. This is an extremely rare subtype of a very rare disease such as pheochromocytoma. However, because the fatality rate of PMC is high, clinicians should be aware of the symptoms that mark its onset.

Identifiers

PMID33434177
PMCPMC7577022
OpenAlexW3088233057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.